These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 15534360

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
    Ghadjar P, Simcock M, Studer G, Allal AS, Ozsahin M, Bernier J, Töpfer M, Zimmermann F, Betz M, Glanzmann C, Aebersold DM, Swiss Group for Clinical Cancer Research (SAKK).
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):524-31. PubMed ID: 21300466
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct 01; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 7. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A, Azria D, Pasche P, Stupp R, Chevalier J, Betz M, Mirimanoff RO, Ozsahin M.
    Radiother Oncol; 2004 Feb 01; 70(2):183-8. PubMed ID: 15028406
    [Abstract] [Full Text] [Related]

  • 8. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE.
    Head Neck; 2004 May 01; 26(5):447-55. PubMed ID: 15122662
    [Abstract] [Full Text] [Related]

  • 9. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):410-21. PubMed ID: 16168834
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
    Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M, European Organization for Research and Treatment of Cancer Trial 22931.
    N Engl J Med; 2004 May 06; 350(19):1945-52. PubMed ID: 15128894
    [Abstract] [Full Text] [Related]

  • 12. Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma.
    Amrein PC, Clark JR, Supko JG, Fabian RL, Wang CC, Colevas AD, Posner MR, Deschler DG, Rocco JW, Finkelstein DM, McIntyre JF.
    Cancer; 2005 Oct 01; 104(7):1418-27. PubMed ID: 16116597
    [Abstract] [Full Text] [Related]

  • 13. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
    Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J, Forastiere AA, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2005 May 20; 23(15):3562-7. PubMed ID: 15908667
    [Abstract] [Full Text] [Related]

  • 14. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
    Maguire PD, Meyerson MB, Neal CR, Hamann MS, Bost AL, Anagnost JW, Ungaro PC, Pollock HD, McMurray JE, Wilson EP, Kotwall CA.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):698-704. PubMed ID: 14967423
    [Abstract] [Full Text] [Related]

  • 15. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.
    Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT, Prosnitz LR.
    N Engl J Med; 1998 Jun 18; 338(25):1798-804. PubMed ID: 9632446
    [Abstract] [Full Text] [Related]

  • 16. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H, Tsukuda M, Watai K.
    Cancer Chemother Pharmacol; 2007 Aug 18; 60(3):399-406. PubMed ID: 17096160
    [Abstract] [Full Text] [Related]

  • 17. Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer.
    Beckmann GK, Hoppe F, Pfreundner L, Flentje MP.
    Head Neck; 2005 Jan 18; 27(1):36-43. PubMed ID: 15459918
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experience.
    Zamboglou N, Schnabel T, Kolotas C, Achterrath W, Strehl H, Dalhäuser S, Vogt HG, Lenaz L, Schmitt G.
    Semin Oncol; 1994 Oct 18; 21(5 Suppl 12):45-53. PubMed ID: 7992066
    [Abstract] [Full Text] [Related]

  • 20. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.
    Jeremic B, Milicic B, Dagovic A, Vaskovic Z, Tadic L.
    J Clin Oncol; 2004 Sep 01; 22(17):3540-8. PubMed ID: 15337803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.